Australia's Atomo Diagnostics jumps on $3.4 mln HIV test supply deal

Atomo Diagnostics

14/01/2025 02:37

** Atomo Diagnostics  AT1.AX  soars as much as 11.1% to
A$0.020; biggest intraday gain since Dec. 5, 2024
    ** Medical devices maker executes new long-term supply
agreement for its HIV self-test device
    ** Five-year deal with existing distribution partner
Newfoundland Diagnostics worth ~A$5.4 mln ($3.4 mln)
    ** Deal grants Newfoundland exclusive distribution rights to
supply Atomo's test in the UK and non-exclusive rights for the
EU and Colombia
    ** AT1 up 5.3% YTD

($1 = A$1.6184)

 (Reporting by Adwitiya Srivastava in Bengaluru)
 ((Adwitiya.Srivastava@thomsonreuters.com;))